3 Einträge gefunden

1. Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations

   1. Marchetti, M
   2. Barosi, G
   3. Cervantes, F
   4. Birgegård, G
   5. Griesshammer, M
   6. Harrison, C
   7. Hehlmann, R

   2017 - Forschungsinformationssystem des UKE
2. Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

   1. Vannucchi, A M
   2. Barbui, T
   3. Cervantes, F
   4. Harrison, C
   5. Kiladjian, J-J
   6. Kröger, Nicolaus
   7. Thiele, J

   2015 - Forschungsinformationssystem des UKE
3. Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)

   1. Barosi, G
   2. Tefferi, A
   3. Besses, C
   4. Birgegard, G
   5. Cervantes, F
   6. Finazzi, G
   7. Gisslinger, H

   2014 - Forschungsinformationssystem des UKE